Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:49 PM
Ignite Modification Date:
2025-12-24 @ 7:49 PM
NCT ID:
NCT06261203
Eligibility Criteria:
Inclusion Criteria:
* Singleton pregnancy
* Before 8 weeks gestation
* Women at high risk of preeclampsia according to Royal College of Obstetricians and Gynecologists (RCOG) (Robson et al., 2013):
* Maternal age ≥ 35 years.
* Nulliparity.
* BMI ≥ 30 kg/m2.
* Smoking of r ≥ 10 cigarettes per day.
* Previous history of small for gestational age (SGA) baby.
* Previous history of stillbirth.
* Pregnancy interval \< 6 months or ≥ 60months.
* Chronic hypertension.
* Diabetes with vascular disease.
* Willingness to participate in the study and provide informed written consent.
Exclusion Criteria:
* Known allergy or hypersensitivity to aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs)
* Use of any anticoagulant medication (e.g., heparin, warfarin, clopidogrel)
* Use of low-dose aspirin for any indication prior to the current pregnancy
* Chronic use of NSAIDs or corticosteroids
* History of bleeding disorder or active bleeding
* Any medical condition that may contraindicate the use of low-dose aspirin (e.g., peptic ulcer disease, asthma, liver, or kidney disease)
* Multiple gestation
* Inability to provide informed consent or comply with the study requirements.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
40 Years
Study:
NCT06261203
Study Brief:
Protocol Section:
NCT06261203